Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

151 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
WDRPUH, a novel WD-repeat-containing protein, is highly expressed in human hepatocellular carcinoma and involved in cell proliferation.
Silva FP, Hamamoto R, Nakamura Y, Furukawa Y. Silva FP, et al. Neoplasia. 2005 Apr;7(4):348-55. doi: 10.1593/neo.04544. Neoplasia. 2005. PMID: 15967112 Free PMC article.
Enhanced methyltransferase activity of SMYD3 by the cleavage of its N-terminal region in human cancer cells.
Silva FP, Hamamoto R, Kunizaki M, Tsuge M, Nakamura Y, Furukawa Y. Silva FP, et al. Oncogene. 2008 Apr 24;27(19):2686-92. doi: 10.1038/sj.onc.1210929. Epub 2007 Nov 12. Oncogene. 2008. PMID: 17998933
TIPUH1 encodes a novel KRAB zinc-finger protein highly expressed in human hepatocellular carcinomas.
Silva FP, Hamamoto R, Furukawa Y, Nakamura Y. Silva FP, et al. Oncogene. 2006 Aug 17;25(36):5063-70. doi: 10.1038/sj.onc.1209517. Epub 2006 Mar 27. Oncogene. 2006. PMID: 16568080
The lysine 831 of vascular endothelial growth factor receptor 1 is a novel target of methylation by SMYD3.
Kunizaki M, Hamamoto R, Silva FP, Yamaguchi K, Nagayasu T, Shibuya M, Nakamura Y, Furukawa Y. Kunizaki M, et al. Among authors: silva fp. Cancer Res. 2007 Nov 15;67(22):10759-65. doi: 10.1158/0008-5472.CAN-07-1132. Cancer Res. 2007. PMID: 18006819
Enhanced SMYD3 expression is essential for the growth of breast cancer cells.
Hamamoto R, Silva FP, Tsuge M, Nishidate T, Katagiri T, Nakamura Y, Furukawa Y. Hamamoto R, et al. Among authors: silva fp. Cancer Sci. 2006 Feb;97(2):113-8. doi: 10.1111/j.1349-7006.2006.00146.x. Cancer Sci. 2006. PMID: 16441421
A variable number of tandem repeats polymorphism in an E2F-1 binding element in the 5' flanking region of SMYD3 is a risk factor for human cancers.
Tsuge M, Hamamoto R, Silva FP, Ohnishi Y, Chayama K, Kamatani N, Furukawa Y, Nakamura Y. Tsuge M, et al. Among authors: silva fp. Nat Genet. 2005 Oct;37(10):1104-7. doi: 10.1038/ng1638. Epub 2005 Sep 11. Nat Genet. 2005. PMID: 16155568
SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells.
Hamamoto R, Furukawa Y, Morita M, Iimura Y, Silva FP, Li M, Yagyu R, Nakamura Y. Hamamoto R, et al. Among authors: silva fp. Nat Cell Biol. 2004 Aug;6(8):731-40. doi: 10.1038/ncb1151. Epub 2004 Jul 4. Nat Cell Biol. 2004. PMID: 15235609
Altered expression of MLL methyltransferase family genes in breast cancer.
Rabello Ddo A, de Moura CA, de Andrade RV, Motoyama AB, Silva FP. Rabello Ddo A, et al. Among authors: silva fp. Int J Oncol. 2013 Aug;43(2):653-60. doi: 10.3892/ijo.2013.1981. Epub 2013 Jun 10. Int J Oncol. 2013. PMID: 23754336
SET domain-containing Protein 4 (SETD4) is a Newly Identified Cytosolic and Nuclear Lysine Methyltransferase involved in Breast Cancer Cell Proliferation.
Faria JA, CorrĂȘa NC, de Andrade C, de Angelis Campos AC, Dos Santos Samuel de Almeida R, Rodrigues TS, de Goes AM, Gomes DA, Silva FP. Faria JA, et al. Among authors: silva fp. J Cancer Sci Ther. 2013 Jan 21;5(2):58-65. J Cancer Sci Ther. 2013. PMID: 24738023 Free PMC article.
Long-term in vitro treatment with telomerase inhibitor MST-312 induces resistance by selecting long telomeres cells.
Morais KDS, Arcanjo DDS, de Faria Lopes GP, da Silva GG, da Mota THA, Gabriel TR, Rabello Ramos DDA, Silva FP, de Oliveira DM. Morais KDS, et al. Among authors: silva fp. Cell Biochem Funct. 2019 Jun;37(4):273-280. doi: 10.1002/cbf.3398. Epub 2019 Apr 23. Cell Biochem Funct. 2019. PMID: 31012504
151 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page